Science Market Update
The University of Alabama in Birmingham runs one of an elite group of Comprehensive Cancer Centers in the United States, as designated by the National Cancer Institute (NCI). The NCI's Translational Research Program is in charge of administering SPORE awards, which are focused on specific organ sites. Now UAB is also a SPORE grantee for its brain tumor program, thanks to a recent $2.3M award over three years to its Cancer Center in conjunction with the UAB Division of Neurosurgery. UAB is one of only four institutions to receive a brain-tumor SPORE grant.
Despite controversy surrounding stem cell research, researchers at the University of Alabama at Birmingham, partnering with SANYO corporation, are pressing forward with a new machine representing a breakthrough in the treatment of patients using stem cells.
Science research at the University of Alabama, Birmingham has led to a new, simple, and cost-effective test for the cytomegalovirus infection that may cause acute hearing loss in infants.
The biotechnology sector is growing and graduate students in the University of Alabama at Birmingham's Master's Program in Biotechnology are ready to build their careers (and Birmingham's biotech future) on that promise. While there are several innovative business-science hybrid master's programs that have emerged recently in the US (see our two April 12 blogs), UA's is the first in the South and unique in its approach.